我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

不同体质量指数对非高血压人群进展为高血压病的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第3期
页码:
333-337
栏目:
临床研究
出版日期:
2018-03-25

文章信息/Info

Title:
The impact of different body mass index on the progression to hypertension in non-hypertensive population
作者:
邓智辉1; 白煜佳1; 严传杰2; 詹 琼1; 黄兴福1; 曾庆春1; 戴 萌2; 许顶立1
（南方医科大学南方医院：1.心血管内科，2.健康管理科，广东 广州 510515）
Author(s):
DENG Zhi-hui1;  BAI Yu-jia1;  YAN Chuan-jie2;  ZHAN Qiong1;  Huang Xing-fu1;  ZENG Qing-chun1;  DAI Meng2;  XU Ding-li1
(1.Department of Cardiology, 2.Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China)
关键词:
高血压; 原发性; 体质量指数; 超重; 肥胖
Keywords:
-
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
目的 探讨不同体质量指数（body mass index,BMI）对非高血压人群进展为高血压病的影响。方法 选择参加年度体检并完成至少2次的体检者，根据基线BMI分为低体质量组（BMI<18.5）、正常体质量组（18.5≤BMI<24）、超重组（24≤BMI<28）和肥胖组（BMI≥28），比较各组的临床特点及高血压病发病率的差异。进一步根据基线不同血压水平将体检者分为正常血压组和正常高值组两个亚组，采用多因素COX回归分析基线不同血压下BMI对高血压进展的影响。结果 基线入选非高血压者23 665人，平均随访3.6年后，共有2 502人进展为高血压病。低体质量组、正常体质量组、超重组和肥胖组的高血压病发病率分别为2.80%、6.41%、17.88%和27.84%，从低体质量组到肥胖组呈递增趋势（P<0.01）。多因素Cox回归分析结果显示，在校正其他混杂因素后，高血压发病风险从正常体质量组到肥胖组依次升高。其中超重组、肥胖组的高血压发病风险分别是正常体质量组的1.22倍（95%CI 1.12~1.34，P<0.01）、1.35倍（95%CI 1.19~1.53，P<0.01）。无论在正常血压组还是正常高值组，这种高血压发病风险从正常体质量组到肥胖组依次升高的趋势均存在。结论 随基线BMI的增加，高血压病发病率和发病风险升高。
Abstract:
AIM To investigate the impact of different body mass indexes on progression to hypertension in non-hypertensive population. METHODS Subjects who participated in annual physical examinations and completed a minimum of 2 times were selected and they were divided into low weight group (BMI<18.5), normal weight group (18.5≤BMI<24), overweight group (24≤BMI<28) and obesity group (BMI≥28), according to baseline BMI. Clinical features were evaluated and incidence of hypertension was compared among four groups. According to different blood pressures at baseline, the subjects were divided into normal blood pressure group and high-normal blood pressure group. Multivariate Cox regression was used to analyze the effect of BMI at different blood pressure at baseline on the progression of hypertension. RESULTS 23 665 non-hypertensive subjects at baseline were enrolled.A total of 2 502 subjects developed hypertension after a mean follow-up of 3.6 years.The incidence of hypertension increased from low weight group to obesity group and were 2.80%, 6.41%, 17.88%, 27.84% in the low weight group, normal weight group, overweight group, and obesity group, respectively. Multivariate Cox regression analysis showed that the risk of hypertension increased from the normal weight group to the obesity group after adjusted for other confounding factors. The risk of hypertension in the overweight group and the obesity group were 1.22 times and 1.35 times higher than the normal weight group. This trend of increasing risk of hypertension from normal weight group to obesity group existed both in the normal group and the high normal group. CONCLUSION The incidence and risk of hypertension increase with increment of baseline body mass index.

参考文献/References

[1]Xi B,Liang Y,Reilly KH,et al.Trends in prevalence,awareness,treatment,and control of hypertension among Chinese adults 1991-2009[J].Int J Cardiol,2012,158(2):326-329.

[2]陈伟伟，高润霖，刘力生，等.《中国心血管病报告2015》概要[J].中国循环杂志,2016,31(6):617-622.

[3]Chen Z,Smith M,Du H,et al.Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women[J].Int J Epidemiol,2015,44(4):1305-1319.

[4]Gnatiuc L,Alegredíaz J,Halsey J,et al.Adiposity and blood pressure in 110 000 Mexican adults[J].Hypertension,2017,69(4):608-614.

[5]Gu D,Wildman RP,Wu X,et al.Incidence and predictors of hypertension over 8 years among Chinese men and women[J].J Hypertens,2007,25(3):517-523.

[6]Paynter NP,Cook NR,Everett BM,et al.Prediction of incident hypertension risk in women with currently normal blood pressure[J].Am J Med,2009,122(5):464-471.

[7]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.

[8]中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.

[9]刘明波，李镒冲，刘世炜，等.2010年中国人群高血压疾病负担[J].中华流行病学杂志,2014,35(6):680-683.

[10]中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10.

[11]Herrington WG,Smith M,Bankhead C,et al.Body-mass index and risk of advanced chronic kidney disease:Prospective analyses from a primary care cohort of 1.4 million adults in England[J].PLoS One,2017,12(3):e0173515.

[12]王志宏，张 兵，王惠君，等.我国成年人体质量指数及动态变化对高血压发病的影响[J].中华高血压杂志,2010,18(12):1173-1176.

[13]Gelber R,Gaziano J,Manson J,et al.A prospective study of body mass index and the risk of developing hypertension in MEN[J].Am J Hypertens,2007,20(4):370-377.

[14]赵楚敏,王希柱,宋巧凤,等.18~30岁人群体质量指数与高血压发病的关系［J］. 中华高血压杂志,2015,2015(4):343-348.

[15]Rumantir MS,Vaz M,Jennings GL,et al.Neural mechanisms in human obesity-related hypertension[J].J Hypertens,1999,17(8):1125-1133.

[16]Krum H,Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].Lancet,2009,373(9671):1128-1275.

[17]Esler MD,Krum H,Sobotka PA,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomised controlled trial[J].Lancet,2010,376(9756):1190-1903.

[18]蒋雄京,梁 拓，董 徽，等.经导管射频消融肾交感神经治疗难治性高血压的近期疗效和安全性[J].中华医学杂志,2012,92(46):3265-3268.

[19]Kadziela J,Prejbisz A,Kostka-jeziorny K,et al.Effects of renal sympathetic denervation on blood pressure and glycemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry)[J].Kardiol Pol,2016,74(9):961-968.

[20]Chen W,Leo S,Weng C,et al.Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension[J].Herz,2015,40(Suppl 2):190-196.

[21]Mattu HS,Randeva HS.Role of adipokines in cardiovascular disease[J].J Endocrinol,2013,216(1):T17-T36.

[22]Rahmouni K,Correia MG,Haynes WG,et al.Obesity-Associated hypertension:new insights into mechanisms[J].Hypertension,2004,45(1):9-14.

[23]Rasouli N,Kern PA.Adipocytokines and the metabolic complications of obesity[J].J Clin Endocrinol Metab,2008,93(11 Suppl 1):S64-S73.

[24]Allison MA,Ix JH,Morgan C,et al.Higher leptin is associated with hypertension:the Multi-Ethnic Study of Atherosclerosis[J].J Hum Hypertens,2013,27(10):617-622.

[25]Prior LJ,Eikelis N,Armitage JA,et al.Exposure to a High-Fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits[J].Hypertension,2010,55(4):862-868.

[26]Tanida M,Shen J,Horii Y,et al.Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats[J].Exp Biol Med(Maywood),2007,232(3):390-397.

[27]Chow WS,Cheung BY,Tso AK,et al.Hypoadiponectinemia as a predictor for the development of hypertension:a 5-Year prospective study[J].Hypertension,2007,49(6):1455-1461.

[28]He J,Whelton PK,Appel LJ,et al.Long-Term effects of weight loss and dietary Sodium reduction on incidence of hypertension[J].Hypertension,2000,35(2):544-549.

[29]Moore LL,Visioni AJ,Qureshi MM,et al.Weight loss in overweight adults and the long-term risk of hypertension:the Framingham study[J].Arch Intern Med,2005,165(11):1298-1303.

[30]Ikeda T,Gomi T,Hirawa N,et al.Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity[J].Hypertension,1996,27(5):1180-1186.

备注/Memo

备注/Memo:
收稿日期：2017-11-27.通讯作者：许顶立，主任医师，主要从事心力衰竭发病机制和高血压病研究 Email：dinglixu@fimmu.com 共同通讯作者：戴萌，副主任医师，主要从事心血管疾病健康管理研究 Email：dm42298@126.com 作者简介：邓智辉，硕士生 Email：drdengzhihui@163.com
更新日期/Last Update: 1900-01-01